PA21 Safety and Efficacy in Adult Chinese Subjects
Status:
Completed
Trial end date:
2020-08-21
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy of PA21 in comparison with sevelamer carbonate (Renvela®)
in lowering and maintaining serum phosphorus in adult Chinese subjects with CKD on dialysis
after 12 weeks of treatment.